Clinical Trials
9 trialsNCT02855944 2023-06-09
ARIEL4: A Study of Rucaparib Versus Chemotherapy BRCA Mutant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients
pharmaand GmbH
Phase 3 Completed
NCT01314833 2020-05-19
Minus Anthracycline or Short-Term Versus Epirubicin and Cyclophosphamide Followed by Paclitaxel Regimen for Adjuvant Breast Cancer Therapy
Fudan University
Phase 3 Completed
NCT00226915 2020-02-17
Trial of Tri-weekly TJ Versus Weekly TJ for Stage II-IV Mullerian Carcinoma
Japanese Gynecologic Oncology Group
Phase 3 Completed
NCT00689156 2018-04-05
READ
Danish Breast Cancer Cooperative Group
Phase 3 Completed
NCT00111007 2014-10-31
A Treatment Combination for Patients With Unresectable Stage III or Stage IV Melanoma
Bayer
Phase 3 Completed
NCT00052468 2014-06-25
AGO-OVAR9
AGO Study Group
Phase 3 Completed
NCT00298415 2013-10-25
Chemotherapy of Elderly Patients With Non-Small-Cell Lung Cancer (NSCLC)
Intergroupe Francophone de Cancerologie Thoracique
Phase 3 Completed
NCT00087802 2009-04-16
Gemcitabine/Oxaliplatin (GEMOX) vs Carboplatin/Paclitaxel (CP) in Non-Small Cell Lung Cancer (NSCLC)
Sanofi
Phase 3 Completed
NCT00144053 2006-01-06
A Phase â…¢ Randomized Study of Mitomycin/Vindesine/Cisplatin Versus Irinotecan/Carboplatin Versus Paclitaxel/Carboplatin With Concurrent Thoracic Radiotherapy for Unresectable Stage â…¢ Non-Small-Cell Lung Cancer
West Japan Thoracic Oncology Group
Phase 3 Completed